Cargando…

Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma

Although the metabolic syndrome is a commonplace topic, its potential threats to public health is a problem that cannot be neglected. As the living conditions improved significantly over the past few years, the morbidity of metabolic syndrome has also steadily risen, and the onset age is becoming yo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Ranran, Liu, Heng, Yuan, Yingdi, Xie, Kaipeng, Xu, Pengfei, Liu, Xiaoyun, Wen, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471064/
https://www.ncbi.nlm.nih.gov/pubmed/28515345
http://dx.doi.org/10.18632/oncotarget.15893
_version_ 1783243881663430656
author Tang, Ranran
Liu, Heng
Yuan, Yingdi
Xie, Kaipeng
Xu, Pengfei
Liu, Xiaoyun
Wen, Juan
author_facet Tang, Ranran
Liu, Heng
Yuan, Yingdi
Xie, Kaipeng
Xu, Pengfei
Liu, Xiaoyun
Wen, Juan
author_sort Tang, Ranran
collection PubMed
description Although the metabolic syndrome is a commonplace topic, its potential threats to public health is a problem that cannot be neglected. As the living conditions improved significantly over the past few years, the morbidity of metabolic syndrome has also steadily risen, and the onset age is becoming younger. The hepatocellular carcinoma (HCC), is one of the most prevalent life-threatening human cancers worldwide, incidence of which is also on the rise, gradually occupied the top of the list associated with metabolic syndrome related complication. Despite the advanced improvement of HCC management, the lifestyle, environmental factors, obesity, hepatitis B virus (HBV) infection have been recognized as risk factors for the development of liver cancer. In recent years, genetic studies, especially the genome-wide association studies (GWASs) were widely performed, a new era of the human genome research was created, which has significantly promoted the study of complex disease genetics. These progresses have contributed to the discovery of abundant number of genomic loci convincingly linked with complex metabolic feature and HCC. In this review, we briefly summarize the association between metabolic syndrome and HCC, focusing on the genetic factors contributed to metabolic syndrome and HCC.
format Online
Article
Text
id pubmed-5471064
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-54710642017-06-27 Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma Tang, Ranran Liu, Heng Yuan, Yingdi Xie, Kaipeng Xu, Pengfei Liu, Xiaoyun Wen, Juan Oncotarget Review Although the metabolic syndrome is a commonplace topic, its potential threats to public health is a problem that cannot be neglected. As the living conditions improved significantly over the past few years, the morbidity of metabolic syndrome has also steadily risen, and the onset age is becoming younger. The hepatocellular carcinoma (HCC), is one of the most prevalent life-threatening human cancers worldwide, incidence of which is also on the rise, gradually occupied the top of the list associated with metabolic syndrome related complication. Despite the advanced improvement of HCC management, the lifestyle, environmental factors, obesity, hepatitis B virus (HBV) infection have been recognized as risk factors for the development of liver cancer. In recent years, genetic studies, especially the genome-wide association studies (GWASs) were widely performed, a new era of the human genome research was created, which has significantly promoted the study of complex disease genetics. These progresses have contributed to the discovery of abundant number of genomic loci convincingly linked with complex metabolic feature and HCC. In this review, we briefly summarize the association between metabolic syndrome and HCC, focusing on the genetic factors contributed to metabolic syndrome and HCC. Impact Journals LLC 2017-03-04 /pmc/articles/PMC5471064/ /pubmed/28515345 http://dx.doi.org/10.18632/oncotarget.15893 Text en Copyright: © 2017 Tang et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review
Tang, Ranran
Liu, Heng
Yuan, Yingdi
Xie, Kaipeng
Xu, Pengfei
Liu, Xiaoyun
Wen, Juan
Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma
title Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma
title_full Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma
title_fullStr Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma
title_full_unstemmed Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma
title_short Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma
title_sort genetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471064/
https://www.ncbi.nlm.nih.gov/pubmed/28515345
http://dx.doi.org/10.18632/oncotarget.15893
work_keys_str_mv AT tangranran geneticfactorsassociatedwithriskofmetabolicsyndromeandhepatocellularcarcinoma
AT liuheng geneticfactorsassociatedwithriskofmetabolicsyndromeandhepatocellularcarcinoma
AT yuanyingdi geneticfactorsassociatedwithriskofmetabolicsyndromeandhepatocellularcarcinoma
AT xiekaipeng geneticfactorsassociatedwithriskofmetabolicsyndromeandhepatocellularcarcinoma
AT xupengfei geneticfactorsassociatedwithriskofmetabolicsyndromeandhepatocellularcarcinoma
AT liuxiaoyun geneticfactorsassociatedwithriskofmetabolicsyndromeandhepatocellularcarcinoma
AT wenjuan geneticfactorsassociatedwithriskofmetabolicsyndromeandhepatocellularcarcinoma